evogene is a plant genomics company, utilizing a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity. evogene offers a complete solution for crop productivity improvement through biotechnology and advanced breeding using a unique technology infrastructure that is based on deep scientific understandings of plant genomics and proprietary computational capabilities. the company has strategic collaborations with world-leading agricultural companies to develop improved seed traits in relation to yield and a-biotic stress (such as tolerance to drought), and biotic stress (such as resistance to disease), in key crops as corn, soybean, wheat and rice. in addition, evogene has earlier stage operations in agriculture chemicals, and seeds focusing on second generation feedstock for biodiesel. the company's headquarters are located in rehovot, israel and is listed for trading on the tel aviv stock exchange (tase: evgn) and on the new york stock exch
Company profile
Ticker
EVGN
Exchange
Website
CEO
Ofer Haviv
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
EVGN stock data
Latest filings (excl ownership)
6-K
Current report (foreign)
2 Apr 24
EFFECT
Notice of effectiveness
29 Mar 24
424B5
Prospectus supplement for primary offering
28 Mar 24
6-K
Current report (foreign)
28 Mar 24
20-F
2023 FY
Annual report (foreign)
28 Mar 24
6-K
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
20 Mar 24
6-K
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
7 Mar 24
F-3
Shelf registration (foreign)
1 Mar 24
6-K
AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan
22 Feb 24
6-K
AgPlenus Announces Licensing & Collaboration Agreement with Bayer
21 Feb 24
Transcripts
EVGN
Earnings call transcript
2023 Q4
7 Mar 24
EVGN
Earnings call transcript
2023 Q3
15 Nov 23
EVGN
Earnings call transcript
2023 Q2
17 Aug 23
EVGN
Earnings call transcript
2023 Q1
18 May 23
EVGN
Earnings call transcript
2022 Q3
17 Nov 22
EVGN
Earnings call transcript
2022 Q2
31 Aug 22
EVGN
Earnings call transcript
2022 Q1
27 May 22
EVGN
Earnings call transcript
2021 Q4
10 Mar 22
EVGN
Earnings call transcript
2021 Q2
11 Aug 21
EVGN
Earnings call transcript
2021 Q1
26 May 21
Latest ownership filings
SC 13G
SILVERARC CAPITAL MANAGEMENT, LLC
14 Feb 24
SC 13G/A
MACQUARIE GROUP LTD
11 Feb 22
SC 13G/A
ARK Investment Management LLC
9 Feb 22
SC 13G/A
ARK Investment Management LLC
16 Feb 21
SC 13G/A
Senvest Management, LLC
12 Feb 21
SC 13G/A
WADDELL & REED FINANCIAL INC
12 Feb 21
SC 13G/A
UBS Group AG
8 Feb 21
SC 13G/A
ALPHA CAPITAL ANSTALT
21 Jan 21
SC 13G/A
ALPHA CAPITAL ANSTALT
2 Nov 20
SC 13G
ARK Investment Management LLC
9 Oct 20
Financial summary
Quarter (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q2 2023
3.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 28 |
Opened positions | 6 |
Closed positions | 4 |
Increased positions | 6 |
Reduced positions | 7 |
13F shares | Current |
---|---|
Total value | 662.25 mm |
Total shares | 1.74 mm |
Total puts | 0.00 |
Total calls | 6.20 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Alpha Capital Anstalt | 1.04 mm | $0.00 |
MS Morgan Stanley | 126.80 k | $135.68 mm |
Silverarc Capital Management | 100.00 k | $107.00 mm |
LPL Financial | 66.59 k | $71.25 mm |
Geode Capital Management | 59.01 k | $63.14 mm |
Renaissance Technologies | 45.40 k | $49.00 k |
Sigma Planning | 44.94 k | $48.09 mm |
Csenge Advisory | 30.56 k | $32.70 mm |
Joel Isaacson & Co. | 30.30 k | $32.42 mm |
UBS UBS Group AG - Registered Shares | 29.02 k | $31.05 mm |
News
Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party'
7 Mar 24
Evogene Q4 EPS $(0.13) Beats $(0.14) Estimate, Sales $578.00K Beat $500.00K Estimate
7 Mar 24
Earnings Scheduled For March 7, 2024
7 Mar 24
Evogene Earnings Preview
6 Mar 24
Casterra Announced New Agreements With Seed Producers in Brazil And Africa To Meet Growing Demand ForIts Elite Castor Seed Varieties
5 Mar 24
Press releases
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
16 Apr 24
Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting
11 Apr 24
Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry
2 Apr 24
Evogene Announces Filing of Annual Report on Form 20-F
28 Mar 24
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
20 Mar 24